Effects of long-term use of HAART on oral health status of HIV-infected subjects

被引:80
作者
Nittayananta, Wipawee [1 ]
Talungchit, Sineepat [2 ]
Jaruratanasirikul, Sutep [3 ]
Silpapojakul, Kachornsakdi [3 ]
Chayakul, Panthip [3 ]
Nilmanat, Ampaipith [4 ]
Pruphetkaew, Nannapat [1 ]
机构
[1] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai 90110, Songkhla, Thailand
[2] Srinakharinwirot Univ, Fac Dent, Dept Oral Surg & Oral Med, Bangkok, Thailand
[3] Prince Songkla Univ, Fac Med, Dept Med, Hat Yai 90110, Songkhla, Thailand
[4] Hat Yai Reg Hosp, Div Med, Hat Yai, Thailand
关键词
HAART; HIV; oral health; oral lesion; risk factor; salivary flow rate; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SALIVARY-GLAND HYPOFUNCTION; WOMENS INTERAGENCY HIV; PAROTID-GLAND; PROTEASE INHIBITORS; HIV/AIDS PATIENTS; DENTAL-CARIES; VIRAL-LOAD; MANIFESTATIONS;
D O I
10.1111/j.1600-0714.2009.00875.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The aim of this study was to determine the effects of long-term use of highly active antiretroviral therapy (HAART) on oral health status of HIV-infected subjects. Methods: Oral examination and measurement of saliva flow rate of both unstimulated and wax-stimulated whole saliva were performed in HIV-infected subjects with and without HAART, and in non-HIV individuals. The following data were recorded; duration and risk of HIV infection, type and duration of HAART, CD4 cell count, viral load, presence of orofacial pain, oral dryness, oral burning sensation, oral lesions, cervical caries, and periodontal pocket. Multiple logistic regression analysis was performed to determine the effects of long-term use of HAART on oral health status of HIV-infected subjects. Results: One hundred and fifty-seven HIV-infected subjects - 99 on HAART (age range 23-57 years, mean 39 years) and 58 not on HAART (age range 20-59 years, mean 34 years) - and 50 non-HIV controls (age range 19-59 years, mean 36 years) were enrolled. The most common HAART regimen was 2 NRTI + 2 NNRTI. HIV-infected subjects without HAART showed greater risks of having orofacial pain, oral dryness, oral lesions, and periodontal pockets than those with short-term HAART (P < 0.01). The subjects with long-term HAART were found to have a greater risk of having oral lesions than those with short-term HAART (P < 0.05). The unstimulated and stimulated salivary flow rates of the subjects with HAART were significantly lower than in those without HAART (P < 0.05). Conclusion: We conclude that long-term HAART has adverse effects on oral health status of HIV-infected subjects.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 67 条
[1]  
Arendorf TM, 1998, J ORAL PATHOL MED, V27, P176
[2]  
Baqui AAMA, 1999, ORAL DIS, V5, P294
[3]  
Bendick C, 2002, J ORAL PATHOL MED, V31, P1, DOI 10.1034/j.1600-0714.2002.310101.x
[4]   Medication usage and dental caries outcome-related variables in HIV/AIDS patients [J].
Bretz, WA ;
Flaitz, C ;
Moretti, A ;
Corby, P ;
Schneider, LG ;
Nichols, CM .
AIDS PATIENT CARE AND STDS, 2000, 14 (10) :549-554
[5]   IMMUNOCYTOCHEMICAL IDENTIFICATION OF HIV (P24) ANTIGEN IN PAROTID LYMPHOID LESIONS [J].
BRUNER, JM ;
CLEARY, KR ;
SMITH, FB ;
BATSAKIS, JG .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1989, 103 (11) :1063-1066
[6]   Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects [J].
Cassone, A ;
Tacconelli, E ;
De Bernardis, F ;
Tumbarello, M ;
Torosantucci, A ;
Chiani, P ;
Cauda, R .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (02) :188-195
[7]   Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV-infection: A prospective case-control study [J].
Cauda, R ;
Tacconelli, E ;
Tumbarello, M ;
Morace, G ;
De Bernardis, F ;
Torosantucci, A ;
Cassone, A .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (01) :20-25
[8]  
CDECOSTA J, 1998, ORAL ONCOL, V34, P413
[9]   Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors:: A new face of oral AIDS? [J].
Ceballos-Salobreña, A ;
Gaitán-Cepeda, LA ;
Ceballos-Garcia, L ;
Lezama-Del Valle, D .
AIDS PATIENT CARE AND STDS, 2000, 14 (12) :627-635
[10]   National Expansion of Antiretroviral Treatment in Thailand, 2000-2007: Program Scale-Up and Patient Outcomes [J].
Chasombat, Sanchai ;
McConnell, Michelle S. ;
Siangphoe, Unaporn ;
Yuktanont, Porntip ;
Jirawattanapisal, Thidaporn ;
Fox, Kimberley ;
Thanprasertsuk, Sombat ;
Mock, Philip A. ;
Ningsanond, Peeramon ;
Lertpiriyasuwat, Cheewanan ;
Pinyopornpanich, Somchai .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (05) :506-512